Does ALPRAZOLAM Cause Macular degeneration? 792 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 792 reports of Macular degeneration have been filed in association with ALPRAZOLAM (Alprazolam). This represents 1.6% of all adverse event reports for ALPRAZOLAM.
792
Reports of Macular degeneration with ALPRAZOLAM
1.6%
of all ALPRAZOLAM reports
0
Deaths
228
Hospitalizations
How Dangerous Is Macular degeneration From ALPRAZOLAM?
Of the 792 reports, 228 (28.8%) required hospitalization, and 1 (0.1%) were considered life-threatening.
Is Macular degeneration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 792 reports have been filed with the FAERS database.
What Other Side Effects Does ALPRAZOLAM Cause?
Drug abuse (8,827)
Toxicity to various agents (7,157)
Completed suicide (4,873)
Drug ineffective (4,040)
Overdose (2,967)
Drug dependence (2,743)
Somnolence (2,461)
Intentional overdose (2,389)
Death (2,317)
Suicide attempt (2,313)
What Other Drugs Cause Macular degeneration?
ADALIMUMAB (1,407)
CARBOXYMETHYLCELLULOSE (828)
PREGABALIN (826)
PREDNISONE (821)
BUDESONIDE (820)
MESALAMINE (810)
METRONIDAZOLE (796)
ATORVASTATIN (794)
ACETAMINOPHEN (793)
CLARITHROMYCIN (791)
Which ALPRAZOLAM Alternatives Have Lower Macular degeneration Risk?
ALPRAZOLAM vs ALPROSTADIL
ALPRAZOLAM vs ALTEPLASE
ALPRAZOLAM vs ALTERNARIA ALTERNATA
ALPRAZOLAM vs ALTHIAZIDE
ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE